Rather, AR(-)/FOXA1(-) tumors rather showed a trend toward better survival in the TMA study.
← all excerpts
Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers.
1
—
—